Dna-based aptamers for human cathepsin g

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/711 (2006.01) A61P 7/02 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2528686

The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G- inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chaing length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.

La présente invention a trait à l'identification d'inhibiteurs non peptidiques de la cathepsine G caractérisés par des niveaux élevés de sélectivité et qui peuvent être utilisés de manière efficace dans le traitement et la prophylaxie d'apparitions de symptômes inflammatoires et de conditions de procoagulation. Les aptamères inhibiteurs de la cathepsine G selon l'invention sont constitués de séquences linéaires d'ADN ou de polynucléotides présentant une longueur de chaîne d'au moins 60 nucléotides et sont sensiblement non aptes à être soumis à un appariement des bases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dna-based aptamers for human cathepsin g does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dna-based aptamers for human cathepsin g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna-based aptamers for human cathepsin g will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1518022

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.